Search
Showing results for "1"
This role will be responsible for independently conducting research into the interaction between type 1 diabetes and exercise.
News & Events
Help our kids reach their potentialYou're invited to join the Early Childhood Development and Learning Collaboration on Monday 15 August from 7pm to help every child reach their potential.
News & Events
Oral insulin studyDiabetes researchers from Perth Children’s Hospital would like to find out whether oral insulin is useful in T1D management and is safe for use in individuals with T1D. They are looking for participants aged 16 – 25 years to be involved in their Oral Insulin 12-week study.
News & Events
Guardian 4 sensorThe Guardian 4 sensor have recently been approved by the Therapeutic Goods Administration for use in Australia.
News & Events
Kids have a 'wild' time at diabetes campKids living with type 1 diabetes got to hang out with peers and have a lot of fun at the Diabetes WA and Perth Children’s Hospital kids’ camp in Bicton recently.
News & Events
Check out our new patient folderCheck out our new and improved patient folder - a comprehensive resource to help families navigate a new type 1 diabetes diagnosis, now and into the future.
Research
Twenty-One Years and Still Going Strong: A Qualitative Study Exploring the Contribution of Young Adult, Adolescent, and Stakeholder Involvement to the ResilienceAdolescence is a period of rapid transformation when meeting targets for optimal diabetes care is often challenging due to competing life demands. For more than two decades a diabetes transition clinic in Sydney, Australia, has sustained positive outcomes and demonstrated aspects of resilience in the care of individuals living with type 1 diabetes (T1D) who have transitioned from paediatric to adult care. Many studies have focused on resilience in acute care setting showever, studies that examine the factors that support resilience in settings that care for individuals with long-term, chronic conditions such as T1D are lacking.
Research
Bringing optimised COVID-19 vaccine schedules to immunocompromised populations: statistical elements and designBringing optimised coronavirus disease 2019 (COVID-19) vaccine schedules to immunocompromised populations (BOOST-IC) is a multi-site, adaptive platform trial designed to assess the effect of different booster vaccination schedules in the Australian immunocompromised population on the immunogenicity, safety and cross-protection against COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants.
Research
The histone demethylase dLsd1 regulates organ size by silencing transposable elementsThe specific role of chromatin modifying factors in the timely execution of transcriptional changes in gene expression to regulate organ size remains largely unknown. Here, we report that in Drosophila melanogaster depletion of the histone demethylase dLsd1 results in the reduction of wing size. dLsd1 depletion affects cell proliferation and causes an increase in DNA damage and cell death.